Prioritizing medicine at the end of life?

In a general benefit-cost analysis of medical treatments, priority should be given to measures for those who are at the end of their life and those who are seriously ill. These are the recommendations made in a study by health economist Professor Stefan Felder from the University of Basel, published in the Journal of Health Economics.

Quelle: IDW Informationsdienst Wissenschaft